Prospect Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Hold
16,554
0.27% 67
2025
Q4
$480K Buy
16,554
+2,640
+19% +$79.2K 0.28% 62
2025
Q3
$386K Buy
13,914
+600
+5% +$15.2K 0.22% 69
2025
Q2
$324K Sell
13,314
-340
-2% -$7.45K 0.2% 72
2025
Q1
$283K Buy
13,654
+1,273
+10% +$32K 0.16% 91
2024
Q4
$292K Hold
12,381
0.16% 86
2024
Q3
$317K Sell
12,381
-1,712
-12% -$43.6K 0.2% 74
2024
Q2
$331K Buy
14,093
+500
+4% +$12.6K 0.25% 57
2024
Q1
$391K Buy
13,593
+470
+4% +$14.1K 0.32% 51
2023
Q4
$431K Buy
+13,123
New +$357K 0.43% 42

Other funds holding ARKG

Prospect Financial Services's ARKG Position: Q1 2026 in Review

Prospect Financial Services held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 16,554 shares worth $437K. The position accounts for 0.27% of the portfolio, ranked #67.

Prospect Financial Services first reported a position in ARKG in Q4 2023 and has held it in 10 quarters since. The position peaked at $480K in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Prospect Financial Services held 16,554 shares of ARK Genomic Revolution ETF worth $437K as of Q1 2026.
  • Prospect Financial Services left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
  • ARK Genomic Revolution ETF made up 0.27% of Prospect Financial Services's portfolio in Q1 2026, its #67 holding.
  • Prospect Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 10 quarters since.
  • Prospect Financial Services's ARK Genomic Revolution ETF position peaked at $480K in Q4 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Prospect Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.